PMID: 37293May 1, 1979

Plasticization of cellulose ethers used in the film coating of tablets

The Journal of Pharmacy and Pharmacology
C A Entwistle, R C Rowe


Plasticizer/polymer interactions have been studied by measuring the intrinsic viscosities of both ethyl cellulose and hydroxypropyl methylcellulose in a series of dialkyl phthalates and in a series of liquid glycols respectively. A correlation was found between the intrinsic viscosity of the polymer/plasticizer solutions and the tensile strength, elongation at rupture and work done in stressing to failure of cast films--the mechanical properties being at a minimum when the intrinsic viscosity was at a maximum. This correlation held only within a homologous series of plasticizers and none was found for plasticizers of different structures. A relationship was found between the lowering of a calculated glass transition temperature of hydroxypropyl methylcellulose in the presence of the plasticizers propylene glycol, polyethylene glycol 200 and glycerol and the intrinsic viscosity of the corresponding solutions--the higher the viscosity the greater the lowering of the transition temperature.


Aug 7, 2013·International Journal of Pharmaceutics·Ariana Qiao Jun LowSui Yung Chan
Jan 28, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nantharat PearnchobR Bodmeier
Oct 31, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·C Remuñán-LópezM J Alonso
May 23, 2001·Advanced Drug Delivery Reviews·J Siepmann, N A Peppas
May 9, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R O Williams, J Liu
May 11, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·L A Felton, J W McGinity
Oct 20, 2011·AAPS PharmSciTech·Aliaa N ElMeshad, Arwa S El Hagrasy
Jul 30, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·J SiepmannR Bodmeier
Apr 9, 1998·Journal of Microencapsulation·Z KnezevicI Jalsenjak
Dec 31, 2002·Pharmaceutical Development and Technology·Bhagwan D Rohera, Nilesh H Parikh
Jul 8, 1998·Pharmaceutical Development and Technology·L StubberudC Graffner
Jul 3, 2015·Drug Development and Industrial Pharmacy·Chutima WiranidchapongWatoo Phrompittayarat
Apr 25, 2007·Drug Development and Industrial Pharmacy·Hakan EroğluLevent Oner
Jan 10, 2002·Journal of Pharmaceutical Sciences·Maarit TarvainenPetteri Paronen
Jul 13, 2002·Journal of Pharmaceutical Sciences·C De BrabanderJ P Remon
Nov 18, 2015·Carbohydrate Polymers·Parameswara Rao ChinnamStephanie L Wunder
Jul 13, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Scott M KrullRajesh N Davé
Jun 1, 1983·The Journal of Pharmacy and Pharmacology·S C Porter, K Ridgway
Jul 1, 1983·The Journal of Pharmacy and Pharmacology·A O Okhamafe, P York
Sep 1, 1981·The Journal of Pharmacy and Pharmacology·P StanleyJ M Newton
Sep 1, 1981·The Journal of Pharmacy and Pharmacology·R C Rowe


Jan 1, 1950·Proceedings of the National Academy of Sciences of the United States of America·J H Hildebrand

Related Concepts

Polyethylene Glycol 200
Muscle Tensile Strength
Drug Formulation Process
Ethers for general anesthesia

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.